Proscia Expands Concentriq Platform with Real-World Data to Enhance Precision Medicine
Proscia has announced a new real-world data offering on its Concentriq platform, integrating over 10 million de-identified pathology images with …
All Posts
BioAge Labs Files for IPO with Focus on Anti-Aging Therapeutics and Metabolic Diseases
BioAge Labs, a clinical-stage biopharmaceutical company specializing in anti-aging and metabolic disease therapeutics, has filed for an initial public offering …
12 Useful Mobile Apps For Life Scientists
(Updated: 2.09.2024) Nowadays mobile devices are ubiquitous with an estimated number of smartphones and tablet PCs to exceed two billion …
Noetik Secures $40 Million Series A to Accelerate AI-Driven Precision Cancer Therapies
Noetik, an emerging biotech firm specializing in the application of artificial intelligence (AI) to oncology, has announced the successful closure …
Brinter AM to Launch 3D Bioprinter to the International Space Station
Brinter AM Technologies Oy has been selected to provide a 3D bioprinter for a European Space Agency (ESA) project aimed …
Novartis' Phase III V-MONO Trial Demonstrates Efficacy of Leqvio in Reducing LDL-C in ASCVD Patients
Novartis has announced that its Phase III V-MONO clinical trial evaluating the small interfering RNA (siRNA) therapy Leqvio (inclisiran) in …
Flagship Pioneering and Quotient Therapeutics Partner with Pfizer to Advance Research in Cardiovascular and Renal Diseases
Flagship Pioneering and its subsidiary Quotient Therapeutics have announced a new research initiative under their strategic partnership with Pfizer to …
Bayer and NextRNA Therapeutics Partner to Develop Novel Small Molecule Drugs Targeting Long Non-Coding RNA in Cancer
Bayer and NextRNA Therapeutics have entered a strategic partnership to develop a new class of small molecule drugs targeting cancers …
US Allocates $50 Million to HP's Microfluidics Semiconductor Fab
The US Department of Commerce has committed up to $50 million to HP for expanding its microfluidics semiconductor fabrication facility …
London Biotechnology Show Makes Grand Return to Unveil Cutting-Edge Advances in Health & Medicine
The London Biotechnology Show is set to return for its second edition in 2025, expanding significantly upon the foundation established …
Microbiotica's Microbiome Medicines Progress to Clinical Trials for Melanoma and Ulcerative Colitis
Microbiotica, a UK-based biopharma company specializing in precision microbiome medicines, has received regulatory approvals to start Phase 1b clinical trials …
LG AI Research Introduces EXAONEPath: A Specialized Model for Histopathology Image Analysis
LG AI Research has unveiled EXAONEPath, a pre-trained model designed specifically for the analysis of histopathological images. These images are …